<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Baraclude</title>
    <link rel="shortcut icon" href="images/testlogo.png" type="image/x-icon">
    <link rel="stylesheet" href="css.css">
    <style>
        body {
            background-color: rgba(196, 241, 255, 0.562);
        }
        .container {
            text-align: center;
            margin-left: 100px;
            margin-right:100px;
        }
        p {
            font-size: 22px; /* Adjust the font size as desired */
            font-style: italic;
            text-align: justify;
            text-justify: inter-word;
          }
          table {
         border-spacing: 30px;
          }
    </style>
</head>
<body>
    <center>
        <h1>BARACLUDE</h1><br>
        <table>
            <tr>
                <td><img src="https://www.magicinepharma.com/img/products/banners/c7d71a4cf1e7932677ece522a0ea2a24.jpg" width="300px" height="300px" alt=""></td>
                <td><img src="https://img.medscapestatic.com/pi/features/drugdirectory/octupdate/BMS16120.jpg" height="300px" alt=""></td>
            </tr>
        </table>
            <div class="container">
                <p>
                    Baraclude is a prescription medication that contains the active ingredient entecavir. It is primarily used in the treatment of chronic hepatitis B virus (HBV) infection. Baraclude belongs to a class of medications known as nucleoside analogues, which work by inhibiting the replication of the hepatitis B virus in the body.

Baraclude is available in oral tablet form and is typically taken once daily. The dosage may vary depending on the individual's age, liver function, and the severity of the HBV infection

                   

                </p>
            </div>
    </center>
    
</body>
</html>